Cancer patients on immunotherapy fare worse if they have recently taken antibiotics, with their response and overall survival rate "crashing."
Sep 13, 2019
0
463
Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.
Nov 8, 2017
0
534
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international ...
Jul 12, 2018
0
129
Results from a large-scale patient population study, recently published in the Annals of the American Thoracic Society, reveal palliative care is associated with a reduced risk of suicide in veterans diagnosed with advanced ...
Aug 10, 2018
0
47
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms ...
Mar 23, 2022
0
126
A very large team of researchers affiliated with institutions across China (and several from Washington University School of Medicine in the U.S.) has found recurrent alterations in prostate cancer in Chinese patients that ...
As far back as Ancient Greece, a sculptured physique has been heralded as the pinnacle of physical perfection. But now, researchers from Japan have found that increased muscle mass doesn't just make you look good, it could ...
Mar 4, 2019
0
65
A new analysis has found that Hispanic lung cancer patients seem to live longer than white or black patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that, ...
Apr 23, 2012
0
0
Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some genetic subtypes, other subtypes continue to evade effective treatment. (New therapies ...
Jan 1, 2016
0
116
Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer. Knowledge of these genomic ...
Jul 9, 2014
0
0
